Key Market Indicator:
F&G: 23
25.838,90 NASDAQ · 47.579,00 DOW · 6.876,60 S&P · 3.937,61 Gold · 64,70 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
Hedge the Peak | Protect your Profits
© PR Newswire
06.11.2025
ISIN: US1124631045
Brookdale Senior Living Inc
BKD
LISTED
NYSE
Brookdale Announces Third Quarter 2025 Results and Increases Adjusted EBITDA Annual Guidance
Article
News Preview
NASHVILLE, Tenn., Nov. 6, 2025 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) ("Brookdale" or the "Company") announced results for the quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US4448591028
Humana Inc
HUM
LISTED
NYSE
Humana Inc. to Present at 2025 Wolfe Research Healthcare Conference
Article
News Preview
Humana Inc. (NYSE: HUM) announced today that Celeste Mellet, Chief Financial Officer, will make a presentation to investors at the Wolfe Research Healthcare Conference on Wednesday, November 19, 2025, at 8:40 a.m. Eastern time. A live audio webcast of the presentation will be available via Humana’s Investor Relations page at https://humana.gcs-we...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: CA25253X2077
DiaMedica Therapeutics, Inc.
DMAC
LISTED
NASDAQ
DiaMedica Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update November 13, 2025
Article
News Preview
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia and acute ischemic stroke, announced today that its third quarter 2025 financial results will be released after the markets close on Wednesday, November 12th. DiaMedica will host a live conference call on T...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
More Info
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
06.11.2025
ISIN: US30050B1017
Evolent Health Inc
EVH
LISTED
NYSE
Evolent and American Oncology Network unveil innovative model seeking to improve cancer care while eliminating prior authorization burden
Article
News Preview
WASHINGTON, Nov. 6, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, and American Oncology Network (AON), one of the nation's fastest-growing community oncology networks, today announced a new model enabling high-quali...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
06.11.2025
ISIN: US30050B1017
Evolent Health Inc
EVH
LISTED
NYSE
Evolent Announces Third Quarter 2025 Results
Article
News Preview
Q3 2025 financial results ahead of expectations. Announces more than $500 million in newly-contracted annualized revenue to launch in 2026. Expands leadership team to support accelerating growth. WASHINGTON, Nov. 6, 2025 /PRNe...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US88025U1097
10X Genomics Inc
TXG
LISTED
NASDAQ
10x Genomics Reports Third Quarter 2025 Financial Results
Article
News Preview
PLEASANTON, Calif., Nov. 6, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the third quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US03763A2078
Astrana Health Inc
AMEH
LISTED
NASDAQ
Astrana Health, Inc. Reports Third Quarter 2025 Results
Article
News Preview
Company to Host Conference Call on Thursday, November 6, 2025, at 2:30 p.m. PT/5:30 p.m. ET Reports total revenue of $956.0 million, up 100% year-over-year, and at the higher end of guidance...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US5324571083
Eli Lilly and Co
LLY
LISTED
NYSE
Lilly announces two new Executive Committee members and expansion of leadership roles to prepare for next wave of growth
Article
News Preview
INDIANAPOLIS, Nov. 6, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the appointment of two new Executive Committee members and the expansion of other senior leaders' roles designed to accelerate one of the industry's most ambitious pipelines, generate new portfolio opportunities, and stre...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US83444M1018
Solventum Corporation
SOLV
LISTED
NYSE
Solventum Reports Third Quarter 2025 Financial Results
Article
News Preview
Reported sales increased 0.7%; organic sales increased 2.7% Expects full year organic sales growth to be at the high end of +2.0% to +3.0% range Increases full year adjusted earnings per share outlook to $5.98 to $6.08 Announces 4-year 'Transform for the Futur...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US2289031005
Artivion Inc
AORT
LISTED
NYSE
Artivion Reports Third Quarter 2025 Financial Results
Article
News Preview
Third Quarter Highlights: Achieved revenue of $113.4 million in the third quarter of 2025 versus $95.8 million in the third quarter of 2024, an increase of 18% on a GAAP basis and 16% on a non-GAAP constant currency basis Net income was $6.5 m...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US89532M1018
Trevi Therapeutics Inc
TRVI
LISTED
NASDAQ
Trevi Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 13, 2025
Article
News Preview
Conference call and webcast to be held at 4:30 p.m. ET NEW HAVEN, Conn., Nov. 6, 2025 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: IE00B91XRN20
Prothena Corporation PLC
PRTA
LISTED
NASDAQ
Prothena Reports Third Quarter 2025 Financial Results and Business Highlights
Article
News Preview
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today reported financial results for the third quarter and first nine months of 2025 and provided business highlights. “We are pleased with the advancement of our late...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
06.11.2025
ISIN: US81728J1097
Sensus Healthcare, Inc.
SRTS
LISTED
NASDAQ
Sensus Healthcare Reports Third Quarter 2025 Financial Results
Article
News Preview
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces financial results for the three and nine months ended September 30, 2025. Highlights of the third quarter of 2025 and subseq...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US2053061030
TruBridge Inc
TBRG
LISTED
NASDAQ
TruBridge Announces Third Quarter 2025 Results
Article
News Preview
TruBridge, Inc. (NASDAQ: TBRG), a leading provider of revenue cycle management and healthcare technology solutions for rural and community healthcare organizations, today announced financial results for the third quarter and nine months ended September 30, 2025. Third Quarter 2025 Highlights All comparisons are to the quarter ended September 30,...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US8753722037
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
Tandem Diabetes Care Announces Third Quarter 2025 Financial Results
Article
News Preview
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2025 and reaffirmed full year 2025 guidance. Third Quarter 2025 and Recent Highlights Achieved record third quarter sales both in the United States (U.S.) and internationa...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US74587B1017
Pulse Biosciences Inc
PLSE
LISTED
NASDAQ
Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences
Article
News Preview
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced plans to participate in two upcoming investor conferences. Stifel 2025 Healthcare Conference, in New York, New York. Management is scheduled to presen...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US6323071042
Natera Inc
NTRA
LISTED
NASDAQ
Natera Reports Third Quarter 2025 Financial Results
Article
News Preview
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today reported its financial results for the third quarter ended September 30, 2025. Recent Financial Highlights Generated total revenues of $592.2 million in the third quarter of 2025, compared to $439.8 million in the third quarter of 2024, an increase of 34...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US74587V1070
Puma Biotechnology Inc
PBYI
LISTED
NASDAQ
Puma Biotechnology Reports Third Quarter 2025 Financial Results
Article
News Preview
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced financial results for the third quarter ended September 30, 2025. Unless otherwise stated, all comparisons are for the third quarter of 2025 compared to the third quarter of 2024. Product revenue, net consists entirely of sales revenue from NERLYNX®, Puma’s first comm...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US45257U1088
Immunome Inc
IMNM
LISTED
NASDAQ
Immunome Reports Third Quarter 2025 Financial Results and Provides Business Update
Article
News Preview
Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced financial results for the quarter ended September 30, 2025, and provided a business update. “Immunome’s pipeline continues to advance,” said Clay B. Siegall, Ph.D., President and Chief Executive...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: CA00288U1066
Abcellera Biologics Inc
ABCL
LISTED
NASDAQ
AbCellera Reports Q3 2025 Business Results
Article
News Preview
AbCellera (Nasdaq: ABCL) today announced financial results for the third quarter of 2025. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated. “AbCellera successfully delivered on two corporate priorities this quarter by starting activities at our new clinical manufacturing facility and substant...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US30161Q1040
Exelixis Inc
EXEL
LISTED
NASDAQ
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in November
Article
News Preview
Exelixis, Inc. (Nasdaq: EXEL) today announced that company management will participate in fireside chats at the following investor conferences in November: Guggenheim 2nd Annual Healthcare Innovation Conference: Exelixis is scheduled to present at 10:30 a.m. ET / 7:30 a.m. PT on Monday, November 10 in Boston. Stifel 2025 Healthcare Conference:...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US09062W2044
BioLife Solutions Inc
BLFS
LISTED
NASDAQ
BioLife Solutions Reports Third Quarter 2025 Financial Results
Article
News Preview
Cell Processing revenue of $25.4 million, up 33% over Q3 2024 GAAP gross margin of 62%  and non-GAAP adjusted gross margin of 64% GAAP...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US26622P1075
Doximity Inc
DOCS
LISTED
NYSE
Doximity Announces Fiscal 2026 Second Quarter Financial Results
Article
News Preview
Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 second quarter ended September 30, 2025. “Our platform continues to grow with new AI tools to save physicians’ time,” said Jeff Tangney, co-founder and CEO of Doximity. “In Q2, a record 650,000 prescribers used our...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: CA60255C8850
Mind Medicine (MindMed) Inc
MNMD
LISTED
NASDAQ
MindMed Reports Q3 2025 Financial Results and Business Updates
Article
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today reported financial results for the third quarter ended September 30, 2025 and provided business updates. “2025 continues to be a year of strong execut...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US1570851014
Cerus Corp
CERS
LISTED
NASDAQ
Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance
Article
News Preview
Cerus Corporation (Nasdaq: CERS) announced today financial results for the third quarter ended September 30, 2025, and provided a business update. “We continue to make great strides in improving the safety and availability of transfused blood components around the globe and the record quarterly product revenue results reflect that progress. Produ...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US53566P1093
Lineage Cell Therapeutics Inc.
LCTX
LISTED
TLV
Lineage Cell Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
Article
News Preview
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf”, cell therapies for serious medical conditions, today reported its third quarter 2025 financial and operating results and will host a conference call today at 4:30 p.m. Eastern Time to discuss these...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US47103J1051
Janux Therapeutics Inc
JANX
LISTED
NASDAQ
Janux Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights
Article
News Preview
Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technologies to its Tumor Activated T Cell Engager (TRACTr), Tumor Activated Immunomodulator (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms, today reported fi...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US56600D1072
Maravai LifeSciences Holdings Inc
MRVI
LISTED
NASDAQ
Maravai LifeSciences Reports Third Quarter 2025 Financial Results
Article
News Preview
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the third quarter ended September 30, 2025, together with other business updates. Quarterly Results: Revenue of $41.6 million, Net loss of $(45.1) milli...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US24661P8077
Delcath Systems, Inc.
DCTH
LISTED
NASDAQ
Delcath Systems to Participate in Upcoming Investor Conferences
Article
News Preview
Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced that management will be attending the following investor conferences: Craig-Hallum Alpha Select Conference on Tuesday, November 18, 2025, in New York, NY Canaccord Genuity MedTech, Di...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: IE00B56GVS15
Alkermes Plc
ALKS
LISTED
NASDAQ
Alkermes to Participate in Two Upcoming Investor Conferences
Article
News Preview
DUBLIN, Nov. 6, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in two upcoming investor conferences. Stifel 2025 Healthcare Conference Date/Time: Thursday, Nov. 13, 2025 at 2:40 p.m. ET (7:40 p.m. GMT)...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: IE00B56GVS15
Alkermes Plc
ALKS
LISTED
NASDAQ
Alkermes to Participate in Two Upcoming Investor Conferences
Article
News Preview
DUBLIN, Nov. 6, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in two upcoming investor conferences. Stifel 2025 Healthcare Conference Date/Time: Thursday, Nov. 13, 2025 at 2:40 p.m. ET (7:40 p.m. GMT)...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US23285D1090
Cytek Biosciences Inc
CTKB
LISTED
NASDAQ
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year
Article
News Preview
The Cytek® Muse® Micro cell analyzer has been named Drug Discovery Solution of the Year in the 2025 BioTech Breakthrough Awards....
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US77313F1066
Rocket Pharmaceuticals Inc
RCKT
LISTED
NASDAQ
Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
Article
News Preview
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today reported financial and recent operational results for the third quarter ending September 30, 2025. “During the third quarter, we maintained disciplin...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US09077V1008
BIOAGE Labs Inc
BIOA
LISTED
NASDAQ
BioAge Labs Reports Third Quarter 2025 Financial Results and Provides Business Updates
Article
News Preview
First participant dosed in Phase 1 trial of BGE-102, oral CNS-penetrant NLRP3 inhibitor, with initial SAD data expected by year-end...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US83601L1026
Sotera Health Co
SHC
LISTED
NASDAQ
Sotera Health Announces Secondary Offering of Common Stock
Article
News Preview
Announcement of launch of secondary stock offering...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US7530181004
Rani Therapeutics Holdings, Inc.
RANI
LISTED
NASDAQ
Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update
Article
News Preview
– Announced up to $1.085 billion collaboration with Chugai Pharmaceutical Co. for multiple high-value therapeutics –...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US5560991094
MacroGenics Inc
MGNX
LISTED
NASDAQ
MacroGenics to Participate in the Stifel 2025 Healthcare Conference
Article
News Preview
ROCKVILLE, MD, Nov. 06, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that Eric Risser, President and CEO of MacroGenics, will participate in a fireside chat at the Stifel 2025 Healthcare Conference on...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US8693671021
Sutro Biopharma Inc
STRO
LISTED
NASDAQ
Sutro Biopharma Reports Third Quarter 2025 Financial Results and Business Highlights
Article
News Preview
– Company announces U.S. FDA clearance of Investigational New Drug (IND) application for STRO-004, its potential best-in-class Tissue Factor ADC; Expects to dose first patient before year-end –...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US82024L1035
Shattuck Labs Inc
STTK
LISTED
NASDAQ
Shattuck Labs Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Article
News Preview
–First participants dosed in Phase 1 clinical trial of SL-325 in healthy volunteers –...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US87918A1051
Teladoc Health Inc
TDOC
LISTED
NYSE
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
Article
News Preview
NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US29664W1053
Esperion Therapeutics Inc
ESPR
LISTED
NASDAQ
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Article
News Preview
ANN ARBOR, Mich., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that on November 4, 2025, the Company granted 23 new employees 77,650 restricted stock units (RSUs) under Esperion’s 2017 Inducement Equity Incentive Plan....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US1920051067
Codexis Inc
CDXS
LISTED
NASDAQ
Codexis Reports Third Quarter 2025 Financial Results
Article
News Preview
Announces signing of $37.8m Supply Assurance Agreement with Merck...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US3795772082
Globus Medical Inc
GMED
LISTED
NYSE
Globus Medical Reports Third Quarter 2025 Results
Article
News Preview
AUDUBON, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US0017441017
AMN Healthcare Services Inc
AMN
LISTED
NYSE
AMN Healthcare Announces Third Quarter 2025 Results
Article
News Preview
Quarterly revenue of $634 million and adjusted EBITDA of $58 million; GAAP income of $0.76/share and adjusted EPS of $0.39...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US15687V1098
Certara Inc
CERT
LISTED
NASDAQ
Certara Reports Third Quarter 2025 Financial Results
Article
News Preview
Updates Full Year 2025 Financial Guidance  Updates Full Year 2025 Financial Guidance...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US23284F1057
CytomX Therapeutics Inc
CTMX
LISTED
NASDAQ
CytomX Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update
Article
News Preview
- CX-2051 Phase 1 data update on track for Q1 2026 -...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US1717571079
Cidara Therapeutics, Inc.
CDTX
LISTED
NASDAQ
Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
Article
News Preview
SAN DIEGO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company or Cidara), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today reported financial results for the third quarter ended September 30, 2025, and provided recent business updates....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US81578P1066
Seer Inc
SEER
LISTED
NASDAQ
Seer Reports Third Quarter 2025 Financial Results
Article
News Preview
REDWOOD CITY, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today reported financial results for the third quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US7291391057
Pliant Therapeutics Inc
PLRX
LISTED
NASDAQ
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
Article
News Preview
Oncology program advancing with data expected in the fourth quarter 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US14147L1089
Cardiff Oncology Inc
CRDF
LISTED
NASDAQ
Cardiff Oncology Reports Third Quarter 2025 Results and Provides Business Update
Article
News Preview
– Announced positive data from the ongoing Phase 2 CRDF-004 trial evaluating onvansertib + standard of care for the treatment of first-line RAS-mutated metastatic colorectal cancer –...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US0144421072
Alector Inc
ALEC
LISTED
NASDAQ
Alector Reports Third Quarter 2025 Financial Results and Provides Business Update
Article
News Preview
Selected lead candidates AL137 for the company’s Alector Brain Carrier (ABC)-enabled anti-amyloid beta antibody in Alzheimer's disease, and AL050 for its ABC-enabled GCase enzyme replacement therapy in Parkinson’s disease; both advancing toward IND-enabling studies...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US23285D1090
Cytek Biosciences Inc
CTKB
LISTED
NASDAQ
Cytek Biosciences to Participate in Upcoming Investor Conferences
Article
News Preview
FREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor conferences....
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Meridian Health Plan of Illinois and Centene Foundation Give $300,000 to Food Pantries to Help Tackle Food Insecurity in Illinois
Article
News Preview
Donations strengthen community food resources for families struggling to access healthy food CHICAGO, Nov. 6, 2025 /PRNewswire/ -- Meridian Health Plan of Illinois, Inc. (Meridian) and Centene Foundation, the philanthropic arm of Centene Corporation (NYSE: CNC),...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US5324571083
Eli Lilly and Co
LLY
LISTED
NYSE
Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans
Article
News Preview
 Medicare beneficiaries with obesity or overweight will have access to Zepbound and orforglipron, if approved, at $50 a month  INDIANAPOLIS, Nov. 6, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced an agreement with the...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Superior HealthPlan and Centene Foundation Make $400,000 Investment to Help Tackle Food Insecurity in Texas
Article
News Preview
Investment strengthens community food resources for families struggling to access healthy meals AUSTIN, Texas, Nov. 6, 2025 /PRNewswire/ -- Superior HealthPlan and Centene Foundation, the philanthropic arm of Centene Corporation (NYSE: CNC), today announced a st...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US19249H1032
Coherus Oncology Inc
CHRS
LISTED
NASDAQ
Arvind Sood joins Coherus Oncology as Chief Strategy and Corporate Affairs Officer
Article
News Preview
– Responsible for Corporate Development, Investor Relations, Government Affairs –...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Avantor, Inc. (AVTR) Shareholders To Inquire About Securities Fraud Class Action
Article
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) common stock between March 5, 2024 and October 28, 2025, inclusive (the “Class Peri...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Baxter International
Article
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Baxter International Inc. (“Baxter” or the “Company”) (NYSE: BAX). Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of...
Themefolio
Profiler
Peergroup
© Newsfile
06.11.2025
ISIN: CA50206C1005
LIR Life Sciences Corp.
SKNY
LISTED
CSE
CSE Bulletin: Fundamental Change - Blackbird Critical Metals Corp./LIR Life Sciences Corp.
Article
News Preview
Toronto, Ontario--(Newsfile Corp. - Le 6 novembre/November 2025) - The common shares of LIR Life Sciences Corp. (SKNY), previously listed as Blackbird Critical Metals Corp. (BBRD), have been approved for listing on the CSE. Listing and disclosure documents will be available at www.thecse.com on the trading date. LIR Life...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: DK0062498333
Novo Nordisk A/S
NOVO B
LISTED
CPH
Novo Nordisk announces agreement with the U.S. Administration to bring GLP-1s to more Americans at a lower cost
Article
News Preview
Novo Nordisk has agreed with the U.S. Administration to lower drug prices beginning in 2026 and expand patient access and affordability for semaglutide ......
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
Indices
DAX, DOW, S&P, FTSE...
Realtime Trading
With & without leverage
Currencies
EUR, USD, JPY, BRL, GBP ....
50 FX-Pairs
Top Conditions, Tied spreads, Mini/Micro
Commodities
Brent, WTI, Coffee, Wheat....
Long & Short
Crude oil, Agricultural & more
Metals
Gold, Silver, Palladium, Platinum
Hedging
Soft-,Heavy-, Precious Metals
Stocks & ETF
TSLA, NFLX, NVDA, MSFT, AAPL ....
Leveraged Equity Trading
USA, Europe, Asia
More information, click here

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2025 Select Sector SPDRs
* * *
More Sector related Investment Ideas
XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2025 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Friday, 07.11.2025, Calendar Week 45, 311th day of the year, 54 days remaining until EoY.